9F13
Crystal structure of HLA-C*12:02 in complex with KAYNVTQAF (KF9), a 9-mer epitope from SARS-CoV-2 Nucleocapsid (N266-274)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2024-02-27 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.953732 |
Spacegroup name | I 1 2 1 |
Unit cell lengths | 62.102, 77.123, 83.110 |
Unit cell angles | 90.00, 100.20, 90.00 |
Refinement procedure
Resolution | 45.270 - 1.610 |
R-factor | 0.2052 |
Rwork | 0.204 |
R-free | 0.23100 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.004 |
RMSD bond angle | 0.653 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.21rc1_5127) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 47.900 | 1.640 |
High resolution limit [Å] | 1.610 | 1.610 |
Rmerge | 0.076 | 0.489 |
Rmeas | 0.082 | 0.530 |
Rpim | 0.032 | 0.202 |
Number of reflections | 49905 | 2442 |
<I/σ(I)> | 14.8 | 3.7 |
Completeness [%] | 100.0 | 100 |
Redundancy | 6.7 | 6.9 |
CC(1/2) | 0.997 | 0.922 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 2% PEG400, 20% PEG3350 |